{"id":"NCT00702468","sponsor":"Jazz Pharmaceuticals","briefTitle":"Evaluate the Maintenance of Effect After Long-term Treatment With Sativex速 in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis","officialTitle":"A Placebo Controlled, Parallel Group, Randomised Withdrawal Study of Subjects With Symptoms of Spasticity Due to Multiple Sclerosis Who Are Receiving Long-term Sativex速.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-11","primaryCompletion":"2009-01","completion":"2009-01","firstPosted":"2008-06-20","resultsPosted":"2011-06-17","lastUpdate":"2023-05-06"},"enrollment":36,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Spasticity","Multiple Sclerosis"],"interventions":[{"type":"DRUG","name":"Sativex","otherNames":["GW-1000-02"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Sativex","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the maintenance of effect after long-term treatment with Sativex速 in subjects with symptoms of spasticity due to Multiple Sclerosis (MS) who have been receiving long-term benefit from treatment with Sativex速.","primaryOutcome":{"measure":"Number of Subjects Who Experience Treatment Failure.","timeFrame":"Week 1- Week 5","effectByArm":[{"arm":"Sativex","deltaMin":8,"sd":null},{"arm":"Placebo","deltaMin":17,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.013"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":11,"exclusionCount":20},"locations":{"siteCount":1,"countries":["United Kingdom"]},"refs":{"pmids":["21878454","25475413"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":18},"commonTop":["Pain","Muscle spasms","Muscle spasticity","Back pain","Diarrhoea"]}}